1 INTRODUCTION
The outbreak of coronavirus disease 2019 (COVID-19) infection has been
widespread all over the world. COVID-19 infection can cause various
complications and pneumothorax secondary to COVID-19 is relatively rare.
Pneumothorax as a complication of COVID-19 infection occurs in 1% of
hospitalized COVID-19 patients1 and 2% of COVID-19
patients in intensive care unit2. Simultaneous
bilateral spontaneous pneumothorax is an extremely rare condition that
is found in only 1% of all patients with spontaneous
pneumothorax3. There have been few reports of
bilateral pneumothorax due to COVID-19. There is no treatment strategy
for secondary spontaneous pneumothorax due to COVID-19. In patients with
poor general condition and who are not fit for surgery, refractory
pneumothorax must be cured by internal therapies (chest drainage,
bronchial occlusion and pleurodesis, and so on). There are various drugs
in pleurodesis and autologous blood is a better adhesion in terms of
efficacy and side effects. We herein report a rare case of a severe
COVID-19 patient with bilateral
refractory pneumothorax treated by combining internal treatments.